Gaush Meditech

Gaush Meditech PEG

The PEG Ratio (Price/Earnings-to-Growth) of Gaush Meditech (2407.HK) as of Nov 4, 2026 is 0.22.

PEG

0.22

Last updated:

PEG Ratio (Price/Earnings-to-Growth) of Gaush Meditech is 2025 0.22 . PEG Ratio (Price/Earnings-to-Growth) of Gaush Meditech was 2024 - . It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Gaush Meditech Stock analysis

What does Gaush Meditech do? Gaush Meditech Ltd. generates revenue through four business segments. The Proprietary Products segment develops and sells surgical equipment, intraocular lenses, and diagnostic and treatment devices for ophthalmic diseases, along with related software and consumables. The Distribution segment distributes branded ophthalmic medical devices and consumables. The Technical Services segment offers after-sales services including warranty, maintenance, and consumables support. The Others segment handles equipment leasing and intellectual property agency services. Products are used in treating conditions like cataracts, glaucoma, and pediatric ophthalmology across various medical specialties. The company's primary customers include hospitals, clinics, and medical institutions specializing in ophthalmology. These institutions purchase proprietary devices, branded consumables, and technical support services. The firm's focus on ophthalmic subspecialties ensures consistent demand for its products and services in the treatment of eye diseases. Revenue streams are diversified across product development, distribution, and post-sale services. The proprietary segment drives innovation with surgical equipment and lenses, while distribution and technical services provide steady income from established medical partners. Equipment leasing and IP services in the Others segment contribute to additional revenue without requiring direct product sales. Gaush Meditech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Gaush Meditech stock

PEG Ratio (Price/Earnings-to-Growth) of Gaush Meditech is 0.22 in 2025.

On Eulerpool you can find the complete historical development of PEG Ratio (Price/Earnings-to-Growth) Gaush Meditech since 2006 – with annual values, charts, and detailed analysis.

The PEG ratio adjusts the P/E ratio by the expected earnings growth rate. A PEG below 1 may indicate an undervalued stock relative to its growth potential.

PEG = P/E Ratio / Expected Annual EPS Growth Rate

To evaluate PEG Ratio (Price/Earnings-to-Growth)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for PEG Ratio (Price/Earnings-to-Growth).

A 'good' varies by industry and company stage. On Eulerpool, you can compare PEG Ratio (Price/Earnings-to-Growth)'s Gaush Meditech with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Gaush Meditech

All Key Metrics — Gaush Meditech